Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipoprotein alterations and atherosclerosis in the elderly

M C Corti1, G M Barbato, G Baggio

  • 1Istituto di Medicina Interna, Università di Padova, Italy. CORTIC@UX1.UNIPD.IT

Current Opinion in Lipidology
|August 1, 1997
PubMed
Summary

Lipoprotein levels in older adults can be misleading due to age-related changes and health conditions. Lipid-lowering drugs benefit those with existing cardiovascular disease, but more research is needed for those without.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Frontoparietal network topology as a neural marker of musical perceptual abilities.

Nature communications·2024
Same author

Gender oncology: recommendations and consensus of the Italian Association of Medical Oncology (AIOM).

ESMO open·2024
Same author

Oral conditions and salivary analysis in HIV-uninfected subjects using preexposure prophylaxis.

Medicina oral, patologia oral y cirugia bucal·2022
Same author

Estimating the real burden of cardiovascular mortality in diabetes.

European review for medical and pharmacological sciences·2019
Same author

Mortality from infectious diseases in diabetes.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2018
Same author

Obesity, Muscular Strength, Muscle Composition and Physical Performance in an Elderly Population.

The journal of nutrition, health & aging·2015

Area of Science:

  • Gerontology
  • Cardiovascular Medicine
  • Lipid Metabolism

Background:

  • Lipoproteins are crucial in atherosclerotic disease pathogenesis.
  • Aging alters lipoprotein metabolism, distribution, and correlates.
  • Comorbidities significantly influence lipoprotein levels in the elderly.

Purpose of the Study:

  • To evaluate the predictive value of lipoprotein levels for cardiovascular risk in older populations.
  • To assess the impact of age-associated changes and comorbidities on lipoprotein associations.
  • To review the efficacy of lipid-lowering therapies in elderly individuals.

Main Methods:

  • Analysis of observational studies focusing on lipoprotein lipids in older adults.
  • Consideration of disease burden and comorbidity in statistical analyses.

Related Experiment Videos

  • Review of intervention trials investigating lipid-lowering drugs in elderly populations.

    • Main Results:

    • Lipoprotein levels can be misclassified in old age due to secondary changes.
    • When accounting for comorbidities, lipoprotein lipids remain associated with cardiovascular and cerebrovascular disease in the elderly.
    • Lipid-lowering drugs effectively reduce mortality in older patients with existing cardiovascular disease.

    Conclusions:

    • Lipoprotein levels require careful interpretation in older adults, considering health status.
    • Evidence supports lipid-lowering interventions for elderly individuals with established cardiovascular disease.
    • Further trials are necessary to determine the benefits of lipid-lowering drugs in elderly individuals without pre-existing cardiovascular disease.